Association of Circulating Adiponectin and Leptin Levels with the Risk of Diabetic Peripheral Neuropathy

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Dec 30

PMID 39735639

Authors

Zongcun Chen

Shasha Fu

Shuchang Lai

Maoxiong Fu

Guankui Du

Affiliations

Soon will be listed here.

Abstract

Background: Adipokines have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and related complications due to their roles in metabolic regulation and inflammation. However, the relationship between these adipokines and diabetic peripheral neuropathy (DPN) remains unclear.

Methods: A case-control study was performed with 198 patients with DPN and 205 T2DM patients without DPN from the Endocrinology Department at the Second Affiliated Hospital of Hainan Medical University. Circulating adiponectin and leptin levels were quantified via enzyme-linked immunosorbent assays. Logistic regression models, adjusting for age, sex, BMI, smoking status, and diabetes duration, were applied to evaluate the associations between adiponectin and leptin levels and DPN risk.

Results: DPN patients exhibited lower adiponectin (P=0.001) and higher leptin (P=0.007) levels than diabetic controls. Confounders-adjusted analyses revealed that higher adiponectin levels correlated with reduced DPN risk (OR, tertile 3 vs. tertile 1: 0.52; 95% CI: 0.30-0.90), whereas elevated leptin levels were linked to increased DPN risk (OR, tertile 3 vs. tertile 1: 1.91; 95% CI: 1.10-3.32). Stratified analyses confirmed consistent findings across subgroups without statistically significant interactions.

Conclusions: Circulating adiponectin and leptin levels correlate with DPN risk in diabetic patients, suggesting their potential as biomarkers for high-risk DPN identification and guiding targeted prevention and management.

References

Matsuda M, Shimomura I . Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Rev Endocr Metab Disord. 2013; 15(1):1-10. DOI: 10.1007/s11154-013-9271-7. View

Sun Q, Yan B, Yang D, Guo J, Wang C, Zhang Q . Serum Adiponectin Levels Are Positively Associated With Diabetic Peripheral Neuropathy in Chinese Patients With Type 2 Diabetes. Front Endocrinol (Lausanne). 2020; 11:567959. PMC: 7724032. DOI: 10.3389/fendo.2020.567959. View

Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies A . Prevention and Management Strategies for Diabetic Neuropathy. Life (Basel). 2022; 12(8). PMC: 9410148. DOI: 10.3390/life12081185. View

Kwon H, Pessin J . Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013; 4:71. PMC: 3679475. DOI: 10.3389/fendo.2013.00071. View

Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini S, Fallah P, Bazi Z . Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag. 2015; 11:55-70. PMC: 4303398. DOI: 10.2147/VHRM.S48753. View

Herder C, Bongaerts B, Ouwens D, Rathmann W, Heier M, Carstensen-Kirberg M . Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy. Diabet Med. 2015; 32(11):1479-83. DOI: 10.1111/dme.12761. View

Mellott E, Faulkner J . Mechanisms of leptin-induced endothelial dysfunction. Curr Opin Nephrol Hypertens. 2023; 32(2):118-123. PMC: 9870925. DOI: 10.1097/MNH.0000000000000867. View

Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z . Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019; 35(6):e3158. DOI: 10.1002/dmrr.3158. View

Ji Z, Li H, Lei Y, Rao Y, Tan Z, Liu H . Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients. J Diabetes Complications. 2015; 29(7):887-92. DOI: 10.1016/j.jdiacomp.2015.06.008. View

10.

Ouchi N, Parker J, Lugus J, Walsh K . Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85-97. PMC: 3518031. DOI: 10.1038/nri2921. View

11.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2017; 41(Suppl 1):S13-S27. DOI: 10.2337/dc18-S002. View

12.

Peng J, Chen Q, Wu C . The role of adiponectin in cardiovascular disease. Cardiovasc Pathol. 2023; 64:107514. DOI: 10.1016/j.carpath.2022.107514. View

13.

Mohanraj P, Das A, Sen A, Ranjan A, Rajendran V, Velu A . Evaluating the Diagnostic Potential of Serum Vascular Endothelial Growth Factor and Adiponectin in Diabetic Peripheral Neuropathy. Cureus. 2024; 16(1):e53017. PMC: 10895556. DOI: 10.7759/cureus.53017. View

14.

Monzillo L, Hamdy O, Horton E, Ledbury S, Mullooly C, Jarema C . Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res. 2003; 11(9):1048-54. DOI: 10.1038/oby.2003.144. View

15.

Elafros M, Andersen H, Bennett D, Savelieff M, Viswanathan V, Callaghan B . Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022; 21(10):922-936. PMC: 10112836. DOI: 10.1016/S1474-4422(22)00188-0. View

16.

Selvarajah D, Kar D, Khunti K, Davies M, Scott A, Walker J . Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019; 7(12):938-948. DOI: 10.1016/S2213-8587(19)30081-6. View

17.

Yu J, Javorschi S, Hevener A, Kruszynska Y, Norman R, Sinha M . The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002; 51(10):2968-74. DOI: 10.2337/diabetes.51.10.2968. View

18.

Goldstein B, Scalia R . Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004; 89(6):2563-8. DOI: 10.1210/jc.2004-0518. View

19.

Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M . Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. Int J Mol Sci. 2023; 24(4). PMC: 9967934. DOI: 10.3390/ijms24043554. View

20.

Nan J, Zhang X, Li D, Jin M, Guo G, Dong J . Effect of Leptin Levels of Type 2 Diabetes Mellitus and Diabetic Complications. Clin Invest Med. 2022; 45(3):E32-46. DOI: 10.25011/cim.v45i3.38873. View